BioLineRx (BLRX) vs GT Biopharma (GTBP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GT Biopharma (GTBP) has outperformed BioLineRx (BLRX) over the past year, gaining 724.5% versus a loss of 50.3%. Over five years, GTBP leads with a -96.6% price change compared with -98.2% for BLRX. BioLineRx is the larger company by market cap ($11.0 million vs $10.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLRX | GTBP |
|---|---|---|
| Share price | $2.21 | $5.96 |
| Market cap | $11.00M | $10.75M |
| 1-day change | +0.23% | -3.87% |
| YTD return | -20.40% | +689.81% |
| 1-year return | -50.34% | +724.47% |
| 5-year return | -98.20% | -96.58% |
| EPS (TTM) | $0.00 | $-147.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.50 | $28.75 |
| 52-week low | $2.15 | $4.91 |
| Distance from 52-week high | -50.89% | -79.27% |
| Average volume | 16.27K | 55.55K |
| Shares outstanding | 4.98M | 1.80M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GTBP has outperformed BLRX by 774.8 percentage points over the past year.
BLRX vs GTBP FAQ
Which is bigger, BioLineRx or GT Biopharma?
BioLineRx (BLRX) is larger, with a market capitalization of $11.00M compared with $10.75M for GT Biopharma (GTBP).
Which stock has performed better over the past year, BLRX or GTBP?
GTBP returned +724.47% over the past 12 months, compared with -50.34% for BLRX (price return, excluding dividends). Past performance does not predict future results.
Are BioLineRx and GT Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.